Company intelligence / Profile preview
AlgoRx Pharmaceuticals
Secaucus, NJ, USAbloomberg.com ↗
- Ownership
- Private
- Employees
- ~5
- Development stage
- Phase 3
01
Overview
VC-backed pain management specialist developing non-opioid analgesics. Merged with Corgentech (2005) to form Anesiva. Lead product Zingo® (lidocaine powder injection) FDA-approved in 2007. ALGRX-4975 capsaicin formulation licensed to Centrexion Therapeutics.
- Therapeutic areas
- RheumatologyNeurology
- Modalities
- Small moleculesNeedleless powder injection systemPure trans-capsaicin formulation
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Corgentech (merger partner)Centrexion Therapeutics (licensee)PowderJect Technologies Ltd. (acquired)
Beyond the preview
Go deeper on AlgoRx Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AlgoRx Pharmaceuticals.